A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 Nov 2017 Status changed from active, no longer recruiting to completed.
- 08 Nov 2017 This trial has been completed in Belgium (End Date:2017-10-05).
- 28 Oct 2017 This trial has been completed in Czech Republic.